5 active trials 2 recruiting 3 disease areas 3 changes in 30 days
| Phase 1/2 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT06270316 | Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease | Fabry Disease | Recruiting | 2026-09-24 |
| NCT06063850 | AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe… | Mesial Temporal Lobe Epilepsy | Recruiting | 2026-08-24 |
| NCT06100276 | Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene… | Amyotrophic Lateral Sclerosis | Active, Not Recruiting | 2025-10-22 |
| NCT04120493 | Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest… | Huntington's Disease | Active, Not Recruiting | 2025-10-21 |
| NCT05243017 | Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease | Huntington Disease | Active, Not Recruiting | 2025-03-10 |
Huntington's Disease (2) · ALS (1) · Epilepsy (1)